CLINICAL_TRIALS
trial_result
· 2015-01-22
Clinical Trial Update: Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) [Phase 2]
Summary
Phase 2 trial of blinatumomab in relapsed/refractory B-precursor acute lymphoblastic leukemia completed; results were posted in January 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen Research (Munich) GmbH | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-01-22